Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma.
Ann Surg
; 272(3): 481-486, 2020 09 01.
Article
in En
| MEDLINE
| ID: mdl-32740235
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatectomy
/
Pancreatic Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Paclitaxel
/
Perioperative Care
/
Carcinoma, Pancreatic Ductal
/
Deoxycytidine
/
Albumins
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Surg
Year:
2020
Document type:
Article
Country of publication:
United States